Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPAR.L Regulatory News (PAR)

  • There is currently no data for PAR

Update on Operations

1 Mar 2013 07:00

RNS Number : 9691Y
Noventa Limited
01 March 2013
 



NOVENTA LIMITED

("Noventa" or the "Company") (AIM: NVTA; ISDX: NV)

 

Update on Operations and Discussions with Lender

And Equity Finance Facility

 

 

1 March 2013

 

Update on Operations and Discussions with Lender

 

Further to the announcement of 11 February 2013, the Board of Noventa provides the following update on the Group's operations:

 

·; Production of tantalum pentoxide concentrate remains at low levels. The Board expects total production of tantalum concentrate to be between 1,700 and 1,900lbs for February.

·; The new production plant at Marropino continues to experience a number of technical issues that result in minimal levels of production from this plant.

·; The follow on analysis of ore grades in the pit at Marropino are materially in line with those outlined in the announcement of 11 February 2013.

·; There have been no material developments at the Group's other interests in Mozambique or the Democratic Republic of Congo.

 

The Board of Noventa remains in discussion with the Lender as regards the future financing of the Group and a further announcement will be made once those discussion reach a conclusion. The Group has sufficient working capital for its needs at this time.

 

Equity Finance Facility

 

The Company has today entered into an Equity Finance Facility ("EFF") with Darwin Strategic Limited ("Darwin"). Darwin is a majority owned subsidiary of Henderson Global Investors' Volantis Capital ("Henderson Volantis")who manage c.$1.5bn of assets.. Darwin is an institutional provider of equity based finance for a variety of sectors in the AIM market. Working in partnership with Henderson Volantis, Darwin specialises in providing AIM companies with flexible, low cost access to capital.

 

The EFF agreement with Darwin and Henderson Volantis provides Noventa with a facility of up to £5 million which (subject to certain limited restrictions) can be drawn down at any time over the next three years. The timing and floor subscription price of any draw down is at the sole discretion of the Company.

 

Noventa is under no obligation to make a draw down and may make drawdowns at its discretion, up to the total value of the EFF, by way of issuing subscription notices to Darwin. Following delivery of a subscription notice, Darwin will subscribe and the Company will allot to Darwin new ordinary 0.8p shares in Noventa ("Ordinary Shares").

 

The subscription price for any Ordinary Shares to be subscribed by Darwin under a subscription notice will be the average of the three lowest Volume Weighted Average Prices ("VWAP") of the Ordinary Shares over the 15 trading days following the subscription notice.

 

Noventa is also obliged to specify in each subscription notice a minimum price below which Ordinary Shares will not be issued to Darwin. The Company will have the right (with the consent of Darwin) to modify that minimum price at any time during the relevant Pricing Period.

 

The number of Ordinary Shares which may be issued under any individual subscription notice may be up to the lower of 25 per cent of the Company's issued share capital following completion of the relevant subscription, or four times the average daily trading volume of Noventa's Ordinary Shares over the 15 trading days preceding the issue of the relevant subscription notice. This may be reduced in certain circumstances, including where the minimum price is not maintained.

 

The maximum amount of a subscription notice may not exceed £500,000 without Darwin's permission. Darwin is entitled to a commission of up to 5 per cent of amounts subscribed but may agree with Noventa in lieu thereof for the subscription price for the Ordinary Shares to be discounted by 5 per cent.

 

There is also an over-allotment facility available to Noventa, under which the Company may authorise Darwin, at Darwin's discretion, to increase the amount of the draw down by up to the aggregate undrawn amount under the EFF. Darwin may direct allotments under the EFF to its parent fund, Henderson Volantis.

 

Darwin and Noventa may mutually agree at the end of the pricing period to a variation of subscription price. This may allow for a larger subscription via any over-allotment facility authorised by the Company.

 

The issuance of a Subscription Notice is conditional upon the satisfaction of certain Subscription Notice Conditions which have been agreed between Darwin and Noventa. Any subscription notice which Noventa may issue will only be valid to the extent that it has the requisite shareholder authority to issue the maximum number of Ordinary Shares that Darwin may be required to subscribe under the relevant subscription notice.

 

Darwin and Noventa may terminate the EFF agreement if certain conditions are not met.

 

In conjunction with the EFF, Noventa has entered into a warrant agreement with Darwin dated today to subscribe for up to 1% of issued Ordinary Shares, such warrants to be exercisable at 30% premium to the average VWAP over the next 5 trading days, subject to certain conditions, any time prior to the expiry of 36 months from the date of the warrant agreement.

 

 

(All definitions are as defined in the announcement of 11 February 2013 unless newly defined in this announcement.)

 

For further information please contact:

 

Noventa Limited

Fernando Fernandez-Torres

(Chief Executive Officer)

+258 21 485340

+258 84 3456340

www.noventa.net

Allenby Capital Limited

(Nominated Adviser and Broker)

Nick Harriss/Jeremy Porter/James Reeve

 

+44 20 3328 5656

www.allenbycapital.com

Darwin Strategic Limited

Jamie Vickers / Anand Sambasivan

+44 20 7938 5754

www.darwin-strategic.com

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain information contained or incorporated by reference in this release, including any information as to the Noventa's strategy, projects, plans, prospects, future outlook, anticipated events or results or future financial or operating performance, constitutes "forward-looking statements" within the meaning of Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements can often, but not always, be identified by the use of words such as "plans", "expects", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "predicts", "potential", "continue" or "believes", or variations (including negative variations) of such words; or statements that certain actions, events or results "may", "could", "would", "should", "might", "potential to", or "will" be taken, occur or be achieved or other similar expressions concerning matters that are not historical facts. Readers are cautioned that forward-looking statements are not guarantees of future performance. All of the forward-looking statements made or incorporated in this press release are qualified by these cautionary statements.

 

Forward-looking statements are necessarily based on a number of factors, estimates and assumptions that, while considered reasonable by Noventa as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Readers are also cautioned that forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Noventa to differ materially from those expressed or implied in the forward-looking statements. Certain of these risks and uncertainties are described in more detail in Noventa's Annual Information Form dated 19 July 2011, which is available on SEDAR at www.sedar.com.

 

Although Noventa has attempted to identify statements containing important factors that could cause actual actions, event or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking information contained herein are made as of the date of this document based on the opinions and estimates of management on the date statements containing such forward looking information are made, and Noventa disclaims any obligation to update any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward looking information.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLVLLLXLFZBBL
Date   Source Headline
22nd Sep 20147:00 amRNSStrategy Change and Issue of Convertible Loan Note
9th Jun 20148:30 amRNSIssue of convertible loan notes
3rd Jun 20147:00 amRNSChange of Registered Office
26th Mar 20147:30 amRNSSuspension - Paragon Resources plc
26th Mar 20147:00 amRNSStatement re. Suspension
25th Mar 20147:01 amRNSHolding in Company
19th Mar 20147:00 amRNSIssue of Equity
3rd Mar 201410:15 amRNSIssue of Equity
24th Feb 20147:00 amRNSAcquisition of interest in Paragon Volta Limited
6th Feb 201410:45 amRNSDirector Shareholding
3rd Feb 201410:46 amRNSHalf Yearly Report
10th Jan 20143:00 pmRNSHolding in Company
27th Nov 201312:25 pmRNSResult of AGM
21st Nov 20137:00 amRNSIssue of Equity
4th Nov 20133:30 pmRNSNotice of AGM
30th Oct 201311:00 amRNSInvestment in Greenstar, Appointment of CEO etc...
3rd Sep 201310:00 amRNSIssue of Equity
22nd Aug 20132:16 pmRNSAppointment of special adviser to the Board
12th Aug 20137:00 amRNSCancellation of contract & appointment of Director
8th Aug 20137:00 amRNSIssue of Equity
30th Jul 201310:28 amRNSFinal Results and appointment of Director
24th Jul 20134:26 pmRNSResult of Class Meeting
17th Jul 201312:45 pmRNSAdjournment of class meeting
11th Jul 20134:35 pmRNSPrice Monitoring Extension
24th Jun 201311:30 amRNSUpdate on Sales Process
21st Jun 20133:00 pmRNSIssue of Equity & Change of Name
19th Jun 20132:12 pmRNSResult of EGM
12th Jun 20132:16 pmRNSAdjournment of Class Meeting and EGM
3rd Jun 201311:00 amRNSUpdate Sale Process
15th May 201311:08 amRNSNotice of EGM
11th Apr 201310:00 amRNSDirectorate Change and Settlement Agreement
18th Mar 201311:16 amRNSIssue of Equity and Trading Update
1st Mar 20137:00 amRNSUpdate on Operations
11th Feb 20137:41 amRNSProduction update
5th Feb 201312:15 pmRNSCease to be reporting issuer in Canada
17th Jan 20137:00 amRNSPreference Share Dividend
28th Dec 20123:21 pmRNSShipment of Tantalum Pentoxide Concentrate
14th Dec 20121:00 pmRNSCease to be a reporting issuer in Canada
29th Nov 201212:00 pmRNSHolding(s) in Company
28th Nov 20127:00 amRNSOperations Update
23rd Nov 20127:00 amRNSCompletion of Secured Loan Financing Agreement
20th Nov 20128:39 amRNSLoan Extension
9th Nov 20123:59 pmRNSLoan Extension
1st Nov 201211:11 amRNSLoan Extension
11th Oct 20127:00 amRNSPreference Share Dividend
28th Sep 201212:45 pmRNSLoan Extension
28th Sep 20127:00 amRNSHalf Yearly Report
11th Sep 20127:00 amRNSDirectorate Change
31st Aug 20129:37 amRNSLoan Extension
17th Aug 20124:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.